Walleye Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.71M Buy
43,000
+39,800
+1,244% +$3.54M ﹤0.01% 2208
2026
Q2
$289K Sell
3,200
-14,600
-82% -$1.22M ﹤0.01% 3210
2026
Q1
$1.43M Buy
17,800
+14,500
+439% +$1.2M 0.01% 1755
2025
Q4
$281K Buy
3,300
+2,500
+313% +$205K ﹤0.01% 3355
2025
Q3
$62.2K Sell
800
-3,900
-83% -$305K ﹤0.01% 3915
2025
Q2
$368K Sell
4,700
-18,100
-79% -$1.35M ﹤0.01% 2905
2025
Q1
$1.65M Sell
22,800
-19,900
-47% -$1.42M 0.01% 1564
2024
Q4
$3.16M Buy
42,700
+25,900
+154% +$1.81M 0.01% 1387
2024
Q3
$1.11M Sell
16,800
-30,100
-64% -$2.19M ﹤0.01% 2558
2024
Q2
$4.33M Sell
46,900
-22,400
-32% -$1.98M 0.01% 1395
2024
Q1
$6.62M Sell
69,300
-19,500
-22% -$1.64M 0.01% 1099
2023
Q4
$6.77M Buy
88,800
+50,300
+131% +$3.5M 0.01% 912
2023
Q3
$2.67M Buy
38,500
+10,700
+38% +$860K 0.01% 1510
2023
Q2
$2.62M Buy
27,800
+27,700
+27,700% +$2.41M 0.01% 1147
2023
Q1
$8.27K Buy
+100
New +$7.86K ﹤0.01% 3572
2022
Q4
– Sell
-11,500
Closed -$950K – 3312
2022
Q3
$950K Buy
+11,500
New +$1.11M 0.02% 1021
2019
Q3
– Sell
-300
Closed -$18K – 1988
2019
Q2
$18K Sell
300
-300
-50% -$18.1K ﹤0.01% 1539
2019
Q1
$38K Buy
+600
New +$34.2K 0.01% 1261

Other funds holding EW

Walleye Capital's EW Position: Q3 2026 in Review

Walleye Capital increased its Edwards Lifesciences (EW) stake by 5,516% in Q3 2026, buying an estimated $2.04M and bringing the position to 23,362 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2813.

Walleye Capital first reported a position in EW in Q1 2019 and has held it in 15 quarters since. The position peaked at $23.3M in Q4 2025. 1,344 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Walleye Capital held 23,362 shares of Edwards Lifesciences worth $2.02M as of Q3 2026.
  • Walleye Capital bought 22,946 Edwards Lifesciences shares in Q3 2026, an estimated $2.04M.
  • Edwards Lifesciences made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2813 holding.
  • Walleye Capital first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 15 quarters since.
  • Walleye Capital's Edwards Lifesciences position peaked at $23.3M in Q4 2025.
  • 1,344 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.